---
schema_version: "secwatch.filing_event.v1"
accession: "0001789769-25-000024"
form_type: "8-K"
ticker: "TIL"
cik: "0001789769"
company_name: "Instil Bio, Inc."
filed_at: "2025-03-31T23:59:59+00:00"
generated_at: "2026-05-24T02:06:02.785318+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Instil Bio enters $100M at-the-market stock offering with Jefferies

## Summary
- Sales agreement with Jefferies LLC allows ATM sales of up to $100M in common stock.
- Agent receives 3.0% commission on gross sales price per share sold.
- Sales may be made directly on Nasdaq Capital Market; Company not obligated to sell.
- Agreement terminates upon full sale or 10 trading days' notice from either party.
- Prospectus supplement filed March 28, 2025 under effective S-3 registration statement.

## SEC filing metadata
- accession: 0001789769-25-000024
- form_type: 8-K
- ticker: TIL
- cik: 0001789769
- company_name: Instil Bio, Inc.
- filed_at: 2025-03-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1789769/000178976925000024/0001789769-25-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1789769/000178976925000024/til-20250328.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001789769-25-000024
- JSON: https://secwatch.observer/filing/0001789769-25-000024.json
- Plain text: https://secwatch.observer/filing/0001789769-25-000024.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
